Updated efficacy and safety of melflufen in patients with relapsed/refractory multiple myeloma refractory to daratumumab and/or pomalidomide: HORIZON (OP-106)

Autores: Richardson, P. G.; Oriol, A.; Larocca, A.; Rodríguez Otero, Paula; Norkin, M. ; Blade, J.; Cavo, M. ; Hassoun, H.; Leleu, X.; Alegre, A. ; Maisel, C.; Paner, A. ; Mazumder, A. ; Zonder, J. A.; Puig, N.; Harran, J. ; Harmenberg, J.; Thuresson, S.; Zubair, H.; Mateos, M. V.